Amgen expands Indian footprint with $200M tech hub

Amgen Expands in India with $200 Million Tech Hub Investment

Amgen is investing $200 million in a new technology and innovation center in Hyderabad, India in 20251 2 3.
The company plans to make additional significant investments in future years3 5.
The new site will focus on enhancing Amgen's digital capabilities through artificial intelligence and data science1.
It aims to accelerate drug development and advance Amgen's medicine pipeline1 2.

## Details of the Expansion:

Location and Facilities:

The new site is located in HITEC City, Hyderabad1.
It occupies around 524,000 square feet across two towers1.

Workforce:

The site is expected to have about 2,000 employees by the end of 20255.
Currently, around 300 employees are already working there5.

Strategic Importance:

The center will play a critical role in developing and implementing technology and life sciences solutions to enhance Amgen's global digital capabilities1.
It will focus on leveraging AI and data science for innovative healthcare solutions2.

## Impact and Significance:

For Hyderabad and India:

Strengthens Hyderabad's position as a global biotechnology and innovation hub2.
Aligns with India's goal of becoming a leader in biotechnology and pharmaceuticals2.
Expected to generate employment opportunities for skilled professionals in biotechnology, pharmaceuticals, AI, and data science2.

For Amgen:

Expands Amgen's global footprint and enhances its research and development capabilities4.
Allows access to India's talent pool in technology and life sciences1.

Industry Perspective:

Part of a broader trend of pharmaceutical giants expanding their presence in India5.
Reflects the growing importance of AI and data science in drug discovery and development1 2.

This investment marks a significant step in Amgen's global expansion strategy and reinforces India's growing influence in the global healthcare innovation landscape.